Related Experiment Videos
Opioid peptides. Partially modified retro-inverso dermorphin analogues. XIII
M Marastoni1, G Balboni, R Tomatis
1Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Italy.
Farmaco (Societa Chimica Italiana : 1989)
|November 1, 1989
Summary
Retro-inverso modification of dermorphin peptides significantly reduced mu-receptor affinity. This highlights the critical role of the peptide backbone structure in dermorphin peptide activity.
Area of Science:
- Medicinal Chemistry
- Peptide Science
- Pharmacology
Background:
- Dermorphin is a potent opioid peptide with analgesic properties.
- Understanding structure-activity relationships is crucial for developing new therapeutics.
- Peptide modifications can alter receptor binding and biological activity.
Purpose of the Study:
- To investigate the impact of retro-inverso peptide bond modification on dermorphin analogues.
- To assess the effect of these modifications on mu-opioid receptor affinity.
Main Methods:
- Synthesis of dermorphin analogues with a retro-inverso peptide bond at a specific position.
- Evaluation of the binding affinity of these analogues to the mu-opioid receptor.
Main Results:
- Introduction of a retro-inverso peptide bond between Phenylalanine (Phe) and D-Alanine (D-Ala) in dermorphin analogues.
- A significant decrease in mu-receptor affinity was observed in these modified analogues.
Conclusions:
- The backbone structure, particularly the Phe-D-Ala bond, is essential for maintaining high mu-receptor affinity in dermorphin peptides.
- Retro-inverso modification can be a strategy to modulate peptide activity, but it drastically affects affinity at this specific site.